Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram.

Ko WY, Siontis KC, Attia ZI, Carter RE, Kapa S, Ommen SR, Demuth SJ, Ackerman MJ, Gersh BJ, Arruda-Olson AM, Geske JB, Asirvatham SJ, Lopez-Jimenez F, Nishimura RA, Friedman PA, Noseworthy PA.

J Am Coll Cardiol. 2020 Feb 25;75(7):722-733. doi: 10.1016/j.jacc.2019.12.030.

PMID:
32081280
2.

Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy.

Smith JR, Layrisse V, Medina-Inojosa JR, Berg JD, Ommen SR, Olson TP.

Eur J Prev Cardiol. 2020 Jan 22:2047487319898106. doi: 10.1177/2047487319898106. [Epub ahead of print]

PMID:
31967491
3.

Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy.

Geske JB, Driver CN, Yogeswaran V, Ommen SR, Schaff HV.

Am Heart J. 2020 Mar;221:159-164. doi: 10.1016/j.ahj.2019.11.020. Epub 2019 Dec 18.

PMID:
31937404
4.

Reinvigorating Continuing Medical Education: Meeting the Challenges of the Digital Age.

Cullen MW, Geske JB, Anavekar NS, McAdams JA, Beliveau ME, Ommen SR, Nishimura RA.

Mayo Clin Proc. 2019 Dec;94(12):2501-2509. doi: 10.1016/j.mayocp.2019.07.004. Review.

PMID:
31806103
5.

Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy.

Park JB, Kim DH, Lee H, Hwang IC, Yoon YE, Park HE, Choi SY, Kim YJ, Cho GY, Han K, Ommen SR, Kim HK.

Eur J Prev Cardiol. 2019 Dec 1:2047487319889714. doi: 10.1177/2047487319889714. [Epub ahead of print]

PMID:
31787021
6.

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy.

Siontis KC, Ommen SR, Geske JB.

J Am Heart Assoc. 2019 Nov 5;8(21):e014448. doi: 10.1161/JAHA.119.014448. Epub 2019 Oct 30. No abstract available.

7.

Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study.

Lee H, Han K, Park JB, Hwang IC, Yoon YE, Park HE, Choi SY, Kim YJ, Cho GY, Kim HK, Ommen SR.

Sci Rep. 2019 Oct 10;9(1):14565. doi: 10.1038/s41598-019-50993-5.

8.

Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR.

J Am Coll Cardiol. 2019 Aug 6;74(5):645-655. doi: 10.1016/j.jacc.2019.05.053.

PMID:
31370956
9.

Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.

Lee HJ, Kim HK, Jung JH, Han KD, Lee H, Park JB, Kim HM, Kim YJ, Ommen SR.

Stroke. 2019 Sep;50(9):2582-2586. doi: 10.1161/STROKEAHA.119.026048. Epub 2019 Jul 25.

PMID:
31340730
10.

Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing.

Moon S, Liu S, Scott CG, Samudrala S, Abidian MM, Geske JB, Noseworthy PA, Shellum JL, Chaudhry R, Ommen SR, Nishimura RA, Liu H, Arruda-Olson AM.

Int J Med Inform. 2019 Aug;128:32-38. doi: 10.1016/j.ijmedinf.2019.05.008. Epub 2019 May 13.

11.

Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: Wither Our Cognitive Miser.

Ommen SR.

JAMA Cardiol. 2019 Jul 1;4(7):657-658. doi: 10.1001/jamacardio.2019.1438. No abstract available.

PMID:
31116363
12.

Left ventricular ejection hemodynamics before and after relief of outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy and valvular aortic stenosis.

Cui H, Schaff HV, Abel MD, Helder MRK, Frye RL, Ommen SR, Nishimura RA.

J Thorac Cardiovasc Surg. 2020 Mar;159(3):844-852.e1. doi: 10.1016/j.jtcvs.2019.03.071. Epub 2019 Apr 4.

PMID:
31053434
13.

Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure.

Nguyen A, Schaff HV, Nishimura RA, Geske JB, Dearani JA, King KS, Ommen SR.

J Thorac Cardiovasc Surg. 2019 Apr 5. pii: S0022-5223(19)30772-X. doi: 10.1016/j.jtcvs.2019.03.088. [Epub ahead of print]

PMID:
31053431
14.

Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality?

Nguyen A, Schaff HV, Nishimura RA, Geske JB, Ackerman MJ, Bos JM, Dearani JA, Ommen SR.

Ann Thorac Surg. 2019 Sep;108(3):723-729. doi: 10.1016/j.athoracsur.2019.03.026. Epub 2019 Apr 9.

PMID:
30978316
15.

Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.

Meghji Z, Nguyen A, Fatima B, Geske JB, Nishimura RA, Ommen SR, Lahr BD, Dearani JA, Schaff HV.

JAMA Cardiol. 2019 Mar 1;4(3):237-245. doi: 10.1001/jamacardio.2019.0084.

PMID:
30810698
16.

Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.

Zhou W, Bos JM, Ye D, Tester DJ, Hrstka S, Maleszewski JJ, Ommen SR, Nishimura RA, Schaff HV, Kim CS, Ackerman MJ.

J Cardiovasc Transl Res. 2019 Oct;12(5):394-403. doi: 10.1007/s12265-019-09873-6. Epub 2019 Feb 22.

PMID:
30796699
17.

Cost Efficacy of α-Galactosidase A Enzyme Screening for Fabry Disease.

Newman DB, Miranda WR, Matern D, Peck DS, Geske JB, Maleszewski JJ, Ommen SR, Ackerman MJ.

Mayo Clin Proc. 2019 Jan;94(1):84-88. doi: 10.1016/j.mayocp.2018.08.009.

PMID:
30611458
18.

Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery.

Holst KA, Hanson KT, Ommen SR, Nishimura RA, Habermann EB, Schaff HV.

Mayo Clin Proc. 2019 Jan;94(1):66-73. doi: 10.1016/j.mayocp.2018.07.022.

PMID:
30611455
19.

Accuracy of Jet Direction on Doppler Echocardiography in Identifying the Etiology of Mitral Regurgitation in Obstructive Hypertrophic Cardiomyopathy.

Hang D, Schaff HV, Nishimura RA, Lahr BD, Abel MD, Dearani JA, Ommen SR.

J Am Soc Echocardiogr. 2019 Mar;32(3):333-340. doi: 10.1016/j.echo.2018.10.011. Epub 2018 Dec 28.

PMID:
30598365
20.

Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy.

Smith JR, Medina-Inojosa JR, Layrisse V, Ommen SR, Olson TP.

J Clin Med. 2018 Nov 18;7(11). pii: E447. doi: 10.3390/jcm7110447.

21.

Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.

Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):306-315.e3. doi: 10.1016/j.jtcvs.2018.08.062. Epub 2018 Sep 5.

PMID:
30279000
22.

Response by Nguyen et al to Letter Regarding Article, "Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients with Hypertrophic Cardiomyopathy".

Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Ommen SR.

Circulation. 2018 May 22;137(21):2303-2304. doi: 10.1161/CIRCULATIONAHA.118.033776. No abstract available.

PMID:
29784686
23.

Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy.

Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, Ommen SR.

Ann Thorac Surg. 2018 Aug;106(2):447-453. doi: 10.1016/j.athoracsur.2018.03.039. Epub 2018 Apr 19.

PMID:
29679534
24.

Hypertrophic Cardiomyopathy: Clinical Update.

Geske JB, Ommen SR, Gersh BJ.

JACC Heart Fail. 2018 May;6(5):364-375. doi: 10.1016/j.jchf.2018.02.010. Epub 2018 Apr 11. Review.

25.

QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy.

Patel SI, Ackerman MJ, Shamoun FE, Geske JB, Ommen SR, Love WT, Cha SS, Bos JM, Lester SJ.

Acta Cardiol. 2019 Feb;74(1):53-58. doi: 10.1080/00015385.2018.1440905. Epub 2018 Mar 7.

PMID:
29513133
26.

Platelet Function Analyzer 100 and Brain Natriuretic Peptide as Biomarkers in Obstructive Hypertrophic Cardiomyopathy.

Blackshear JL, Safford RE, Thomas CS, Bos JM, Ackerman MJ, Geske JB, Ommen SR, Shapiro BP, Johns GS.

Am J Cardiol. 2018 Mar 15;121(6):768-774. doi: 10.1016/j.amjcard.2017.12.009. Epub 2017 Dec 25.

PMID:
29397107
27.

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).

O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin SA, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud KD, Vermeer A, Wilde A, Favalli V, Guttmann OP, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM.

Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.

PMID:
29191938
28.

Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?

Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD, Ommen SR.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):582-589. doi: 10.1093/ejcts/ezx398.

PMID:
29182736
29.

Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy.

Hang D, Schaff HV, Ommen SR, Dearani JA, Nishimura RA.

J Thorac Cardiovasc Surg. 2018 May;155(5):2096-2102. doi: 10.1016/j.jtcvs.2017.10.054. Epub 2017 Oct 27.

PMID:
29153286
30.

Early Outcomes of Repair of Left Ventricular Apical Aneurysms in Patients With Hypertrophic Cardiomyopathy.

Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Ommen SR.

Circulation. 2017 Nov 14;136(20):1979-1981. doi: 10.1161/CIRCULATIONAHA.117.030593. No abstract available.

PMID:
29133532
31.

Effect of Body Mass Index on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy.

Larsen CM, Ball CA, Hebl VB, Ong KC, Siontis KC, Olson TP, Ackerman MJ, Ommen SR, Allison TG, Geske JB.

Am J Cardiol. 2018 Jan 1;121(1):100-106. doi: 10.1016/j.amjcard.2017.09.026. Epub 2017 Oct 12.

PMID:
29126582
32.

Women with hypertrophic cardiomyopathy have worse survival.

Geske JB, Ong KC, Siontis KC, Hebl VB, Ackerman MJ, Hodge DO, Miller VM, Nishimura RA, Oh JK, Schaff HV, Gersh BJ, Ommen SR.

Eur Heart J. 2017 Dec 7;38(46):3434-3440. doi: 10.1093/eurheartj/ehx527.

33.

Reply: To Add or Not to Add Mitral Valve Surgery to Septal Myectomy in HOCM Patients.

Schaff HV, Hong JH, Nishimura RA, Abel MD, Dearani JA, Ommen SR.

J Am Coll Cardiol. 2017 May 2;69(17):2250-2251. doi: 10.1016/j.jacc.2017.01.067. No abstract available.

34.

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy.

Sugrue A, Killu AM, DeSimone CV, Chahal AA, Vogt JC, Kremen V, Hai J, Hodge DO, Acker NG, Geske JB, Ackerman MJ, Ommen SR, Lin G, Noseworthy PA, Brady PA.

Open Heart. 2017 Feb 23;4(1):e000561. doi: 10.1136/openhrt-2016-000561. eCollection 2017.

35.

Prevalence and Impact of Coexistent Bicuspid Aortic Valve in Hypertrophic Cardiomyopathy.

Padang R, Gersh BJ, Ommen SR, Geske JB.

Heart Lung Circ. 2018 Jan;27(1):33-40. doi: 10.1016/j.hlc.2017.01.020. Epub 2017 Mar 8.

PMID:
28377231
36.

Why we need more septal myectomy surgeons: An emerging recognition.

Maron BJ, Dearani JA, Maron MS, Ommen SR, Rastegar H, Nishimura RA, Swistel DG, Sherrid MV, Ralph-Edwards A, Rakowski H, Smedira NG, Rowin EJ, Desai MY, Lever HM, Spirito P, Ferrazzi P, Schaff HV.

J Thorac Cardiovasc Surg. 2017 Nov;154(5):1681-1685. doi: 10.1016/j.jtcvs.2016.12.038. Epub 2017 Feb 1. No abstract available.

37.

Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.

Bois JP, Geske JB, Foley TA, Ommen SR, Pellikka PA.

Am J Cardiol. 2017 Feb 15;119(4):643-650. doi: 10.1016/j.amjcard.2016.11.010. Epub 2016 Nov 16.

PMID:
27956002
38.

Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures.

Hong JH, Schaff HV, Nishimura RA, Abel MD, Dearani JA, Li Z, Ommen SR.

J Am Coll Cardiol. 2016 Oct 4;68(14):1497-504. doi: 10.1016/j.jacc.2016.07.735.

39.

Hypertrophic Cardiomyopathy-One Case per Year?: A Clarion Call to Do What Is Right.

Ommen SR, Nishimura RA.

JAMA Cardiol. 2016 Jun 1;1(3):333-4. doi: 10.1001/jamacardio.2016.0277. No abstract available.

PMID:
27438115
40.

Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.

Prasad M, Geske JB, Sorajja P, Ommen SR, Schaff HV, Gersh BJ, Nishimura RA.

Catheter Cardiovasc Interv. 2016 Nov 15;88(6):962-970. doi: 10.1002/ccd.26472. Epub 2016 Apr 6.

PMID:
27062082
41.

The Natural History of Nonobstructive Hypertrophic Cardiomyopathy.

Hebl VB, Miranda WR, Ong KC, Hodge DO, Bos JM, Gentile F, Klarich KW, Nishimura RA, Ackerman MJ, Gersh BJ, Ommen SR, Geske JB.

Mayo Clin Proc. 2016 Mar;91(3):279-87. doi: 10.1016/j.mayocp.2016.01.002.

PMID:
26944240
42.

Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy.

Ong KC, Geske JB, Hebl VB, Nishimura RA, Schaff HV, Ackerman MJ, Klarich KW, Siontis KC, Coutinho T, Dearani JA, Ommen SR, Gersh BJ.

Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):604-10. doi: 10.1093/ehjci/jew024. Epub 2016 Feb 27.

PMID:
26922089
43.

Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.

Murphy SL, Anderson JH, Kapplinger JD, Kruisselbrink TM, Gersh BJ, Ommen SR, Ackerman MJ, Bos JM.

J Cardiovasc Transl Res. 2016 Apr;9(2):153-61. doi: 10.1007/s12265-016-9681-5. Epub 2016 Feb 25.

44.

Relation Between Temperature Extremes and Symptom Exacerbation in Patients With Hypertrophic Cardiomyopathy.

Bois JP, Adams JC, Kumar G, Ommen SR, Nishimura RA, Klarich KW.

Am J Cardiol. 2016 Mar 15;117(6):961-5. doi: 10.1016/j.amjcard.2015.12.046. Epub 2015 Dec 31.

45.

Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.

Hong J, Schaff HV, Ommen SR, Abel MD, Dearani JA, Nishimura RA.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):1044-8. doi: 10.1016/j.jtcvs.2015.11.048. Epub 2015 Dec 8.

46.

Septal myectomy in context: Clinical acumen and procedural expertise.

Ommen SR, Dearani JA.

J Thorac Cardiovasc Surg. 2015 Oct;150(4):936-7. doi: 10.1016/j.jtcvs.2015.08.056. Epub 2015 Aug 28. No abstract available.

47.

Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.

Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Nishimura RA, Ralph-Edwards A, Rakowski H, Sherrid MV, Swistel DG, Balaram S, Rastegar H, Rowin EJ, Smedira NG, Lytle BW, Desai MY, Lever HM.

J Am Coll Cardiol. 2015 Sep 15;66(11):1307-1308. doi: 10.1016/j.jacc.2015.06.1333. No abstract available.

48.

Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.

Kebed KY, Bos JM, Anavekar NS, Mulvagh SL, Ackerman MJ, Ommen SR.

Circ Cardiovasc Imaging. 2015 Jul;8(7):e003312. doi: 10.1161/CIRCIMAGING.115.003312. No abstract available.

PMID:
26162782
49.

Role of imaging in evaluation of sudden cardiac death risk in hypertrophic cardiomyopathy.

Geske JB, Ommen SR.

Curr Opin Cardiol. 2015 Sep;30(5):493-9. doi: 10.1097/HCO.0000000000000202. Review.

PMID:
26154072
50.

Phosphodiesterase 5 Inhibitor Use in Men With Hypertrophic Cardiomyopathy.

Ruzek L, Konecny T, Soucek F, Konecny D, Mach L, Ommen SR, Kopecky SL, Nishimura RA.

Am J Cardiol. 2015 Aug 15;116(4):618-21. doi: 10.1016/j.amjcard.2015.05.022. Epub 2015 May 21.

PMID:
26141201

Supplemental Content

Loading ...
Support Center